This inventor holds 1 USPTO granted patent. Top assignee: Novartis Vaccines & Diagnostics, Gmbh. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Ralph M Owen: Innovator in Cartilage Treatment
Introduction
Ralph M Owen is a notable inventor based in Petaluma, CA (US). He has made significant contributions to the field of medical treatments, particularly in addressing articular cartilage disorders. His innovative approach focuses on utilizing insulin-like growth factor I (IGF-I) to enhance cartilage repair and regeneration.
Latest Patents
Ralph M Owen holds a patent for "Compositions and methods for treating articular cartilage disorders." This patent outlines a method for treating mammalian articular cartilage disorders, specifically osteoarthritis and trauma-related cartilage injuries. The method involves increasing the amount of IGF-I at the affected site to a therapeutically effective level, which aids in the maintenance and regeneration of cartilage. The patent emphasizes the administration of single doses of at least 0.01 mg of pharmaceutically effective IGF-I intermittently, with a recommended frequency of about once per week or less.
Career Highlights
Ralph M Owen is associated with Novartis Vaccines & Diagnostics, GmbH, where he applies his expertise in developing innovative treatments. His work has the potential to significantly improve the quality of life for individuals suffering from cartilage-related issues.
Collaborations
Some of his notable coworkers include Marilyn C Pike and Grushenka H I Wolfgang. Their collaborative efforts contribute to the advancement of research and development in the field of cartilage treatment.
Conclusion
Ralph M Owen's contributions to the treatment of articular cartilage disorders through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in medical treatments for cartilage injuries.